GlassScriptPhysician profile
Bret Matthrew Bahn
NPI 1003887043
$13,216.29
in general payments reported to CMS, 2019-2025
53 companies · $1,774 in 2025
The $1,774 reported for 2025 was more than what 75% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,894 · 2020: $825 · 2021: $2,234 · 2022: $1,770 · 2023: $1,114 · 2024: $1,606 · 2025: $1,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,493.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,087.94 | 2019-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $2,008.14 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Osteocool Rf Ablation System |
| Medtronic USA, INC. | $1,873.24 | 2019-2020 | |
| Vertiflex, INC. | $1,405.70 | 2019 | |
| Relievant Medsystems, INC. | $1,120.77 | 2020-2023 | Intracept |
| Abbvie INC. | $639.74 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Nevro Corp. | $564.18 | 2021-2024 | Senza |
| Pfizer INC. | $468.55 | 2019-2024 | |
| Allergan, INC. | $427.79 | 2019-2022 | |
| Abbott Laboratories | $283.58 | 2019-2022 | |
| Amgen INC. | $234.70 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $206.12 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $200.42 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $176.87 | 2019-2024 | Ztlido |
| Janssen Biotech, INC. | $155.21 | 2022-2025 | Tremfya |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Bahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.